What is Predisurge?
Predisurge operates at the intersection of artificial intelligence and vascular medicine, providing sophisticated decision support tools for cardiovascular physicians. The company's core product suite, which includes the PlanOp iSizing and Endoleak Risk Index, utilizes digital twin technology to enhance the precision of aortic sizing and risk assessment. By digitizing the patient anatomy, Predisurge enables clinicians to simulate interventions with greater accuracy, thereby reducing procedural risks and improving long-term patient outcomes. Their business model is uniquely positioned to serve both the clinical market and the medical device industry, facilitating a more streamlined approach to endovascular care through data-driven insights.
How much funding has Predisurge raised?
Predisurge has raised a total of $6.8M across 1 funding round:
Series A
$6.8M
Series A (2023): $6.8M with participation from Liftt and The European Innovation Council
Key Investors in Predisurge
Liftt
LIFTT is a venture capital holding company specializing in deep tech, acting as a catalyst for transforming scientific research into high-impact, sustainable businesses.
The European Innovation Council
The European Innovation Council provides strategic financial support to high-potential startups and SMEs, focusing on breakthrough technologies and market-creating innovations.
What's next for Predisurge?
With the successful closure of this funding round, Predisurge is expected to prioritize the scaling of its AI-powered digital twin platform and the expansion of its collaborative network with leading medical institutions. The strategic roadmap likely involves deepening the integration of its software within existing hospital infrastructure and potentially broadening its product portfolio to address additional vascular pathologies. As the company matures, the focus will shift toward establishing a dominant market presence in the digital cardiovascular space, ensuring that its innovative tools become a standard component of the endovascular surgical planning process. Continued investment in research and development will remain essential to maintaining its competitive edge in the rapidly evolving landscape of medical software.
See full Predisurge company page
